AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celldex Therapeutics, Inc. Director's Dealing 2012

Sep 13, 2012

Director's Dealing

Opens in your device viewer

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2012-09-12

Reporting Person: Davis Thomas Andrew (Sr. VP & CMO)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-12	Incentive Stock Option	$5.69	A	115000	Acquired	2022-09-12	Common Stock (115000)	Direct

F1: 25% vest on September 12, 2013 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.